Katarzyna Radke

Katarzyna Radke is a researcher affiliated with Lund University and its Faculty of Medicine, specializing in Molecular Pediatric Oncology. She contributes to the Lund University Cancer Centre (LUCC) and focuses on neuroblastoma research, particularly in high-risk cases.

• Role: Associate Researcher and Doctoral Student
• Key Collaborators: Daniel Bexell, David Gisselsson Nord

Her work emphasizes personalized medicine, patient-derived xenograft models, and precision oncology, aiming to improve therapeutic outcomes for neuroblastoma. Recent research explores chemoresistance mechanisms and novel treatments like rigosertib.

Her publications span high-impact journals such as Scientific Reports and Science Advances, addressing cancer model systems, therapeutic strategies, and evolutionary unpredictability in tumor modeling. Collaborative efforts include analyzing organoids and xenografts for patient-specific therapies.